8
clinical trials
4
data partnerships
20K
speakers
1K
patients
Explore our research
Discover our ongoing clinical trials and scientific publications.
A medical device for tracking psychiatric symptoms
CallyoVoice is a medical device for psychiatric symptom assessment, powered by our audio-language foundation model — the first dedicated to mental health. It evaluates depression, anxiety, psychosis, mania, insomnia, fatigue, cognitive decline, and more, enabling clinicians to track symptom evolution objectively with minimal burden for the patient.
Our Scientific Committee.
Our research is guided by a committee of leading scientists and clinicians in mental health, neuroscience, and AI.
Thomas Clozel
CEO of Owkin, co-founder of Bioptimus
Description goes here over one to two lines
Raymond Sanchez
Co-founder and former CMO of Cerevel
Description goes here over one to two lines
Pr Paola Pedrelli
Harvard Medical School / Massachusetts General Hospital
Description goes here over one to two lines
Pr Michael Browning
University of Oxford
Description goes here over one to two lines
Pr Frank Bellivier
Fernand Widal Hospital, AP-HP
Description goes here over one to two lines
Pr Raphaël Gaillard
GHU Paris Psychiatrie et Neurosciences
Description goes here over one to two lines
Emmanuel Dupoux
Meta AI Research, École Normale Supérieure
Description goes here over one to two lines
